Rosuvastatin Completed Phase 2 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00555230Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis